|
Kenneth
S.
Prince
Education
Boston College Law School, LL.B., 1975, magna cum laude
Editor, Boston College Law Review
Order of the Coif
University of Pennsylvania, A.B., 1972
Practice
Kenneth Prince is a member of the firm’s global Antitrust Group. From 1992 through 2011, he was the leader of the firm’s global antitrust practice. Since joining the firm in 1975, Mr. Prince has counseled clients in a wide range of industries on the antitrust implications of mergers and acquisitions, joint ventures, horizontal arrangements among competitors, dominant firm conduct, intellectual property licensing, and distribution and pricing arrangements. He maintains an active criminal antitrust defense practice. He regularly appears on behalf of clients before the United States Department of Justice and the Federal Trade Commission. Mr. Prince’s practice involves multinational clients with respect to competition matters both in the United States and abroad.
Experience
- Handling U.S. antitrust aspects for Psychiatric Solutions, Inc. in its acquisition by Universal Health Services (psychiatric hospitals); Cadbury in its acquisition by Kraft Foods (confectionary goods); Sun Pharmaceutical Industries in its acquisition of Taro Pharmaceuticals (Pharmaceuticals); Ciba in its acquisition by BASF SE (Specialty Chemicals), Nokia in its acquisition of NAVTEQ (mobile telephones); Novartis in the divestiture of its medical nutrition business to Nestlé; BOC Group in its acquisition by Linde AG (industrial gases); Corus Group in its acquisition by Tata Steel (steel) and the divestiture of its aluminum business to Aleris International; ATI Technologies in its acquisition by AMD (semiconductors); BASF in its acquisition of Engelhard Corporation (catalysts); Mittal Steel in its acquisition of ISG (steel); Syngenta in its acquisition of Advanta (seeds); Novartis in its acquisition of Eon Labs and its consideration of a bid for Aventis (pharmaceuticals); BASF in its acquisition of Sunoco’s plasticizer businesses (chemicals); Bunge in its acquisition of Central Soya (soybean processing); Novartis in the spin-off and merger of its crop protection business with that of Astra-Zeneca to form Syngenta; BASF in its polyolefin joint venture (Basell) with Shell; Ciba Vision in its acquisition of Wesley-Jessen (contact lenses); BOC Group in the attempted offer by Air Products and Air Liquide (industrial gases); BASF in its acquisition of American Cyanamid (agricultural chemicals); the merger of Sandoz and Ciba-Geigy into Novartis (life sciences); The Seagram Company in its acquisition of 80% of MCA/Universal (entertainment); Cadbury Schweppes in its acquisition of Dr Pepper/7-Up); Asahi Glass Co. and Glaverbel S.A. in their acquisition of AFG Industry (industrial goods)
- Numerous public and non-public Grand Jury investigations, public matters include representation of Cargolux in the Department of Justice air cargo investigation and BASF in the Department of Justice vitamins investigation and related cases
Selected Professional & Business Activities
- Executive Committee, New York Law Institute (1984-1996)
Bar Admissions/Qualifications
Massachusetts
New York
|